Login
Register
Submit a Paper
Propose a Special lssue
Open Access
COMMENTARY
A Commentary on RIPK2: The Hidden Driver of MHC-I Related Immune Suppression in Cancer
Faculty of Medicine, Department of Experimental Medicine 1, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, 91054, Germany
* Corresponding Author: Lydia Meder. Email:
(This article belongs to the Special Issue: Genetic Biomarkers of Cancer: Insights into Molecular and Cellular Mechanisms)
BIOCELL 2025, 49(2), 161-165. https://doi.org/10.32604/biocell.2025.060227
Received 27 October 2024; Accepted 06 January 2025; Issue published 28 February 2025
This article is a commentary on:
Receptor-interacting Protein Kinase 2 is an immunotherapy target in pancreatic cancer
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Keywords
Cite This Article
Copyright © 2025 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
